Streptonigrin, a quinone antitumor antibiotic, has been reported to be effective in human trials. A sensitive and precise microbiological assay for the determination of distribution and concentrations of streptonigrin in the body fluids and tissues of treated mice has been developed in an attempt to supplement successful clinical application of this drug.
Streptonigrin, an antibiotic produced by cultures of Streptomyces flocculus (15) , inhibits a variety of experimental neoplasms including CA755, Wagner and Ridgway osteogenic sarcoma, the transplantable mouse adenocarcinoma E0771, and Walker carcinosarcoma 256 in rats (16) . Inhibition of human cell tumors HS no. 1 and HEp no. 3 in conditioned rats (11, 19) and in Swiss mice (8) by streptonigrin also has been observed. Additionally, streptonigrin was found to possess antiviral activity against the Ruscher virus in mice (6) . In human trials, significant, objective responses have been observed in a wide range of cases of advanced neoplastic disease treated with streptonigrin (17) . This antibiotic has also been shown to be effective in at least short-term regression of advanced cancer, including malignant lymphomas (2) as well as lymphosarcoma, adenocarcinomas, and Hodgkins disease (1, 3, 10, 22) , although severe toxic effects with single daily injection have been noted. However, Sullivan et al. (18) concluded that significant tumor regression and associated clinical benefit occurred in advanced cancer patients when toxic effects were diminished as a result of prolonging the period of streptonigrin administration without concomitant loss of antitumor effects.
Streptonigrin has been reported to inhibit cell division as well as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis in mammalian cell culture (9) . In metabolic studies employing monolayers of HeLa cells, streptonigrin was found to inhibit incorporation of RNA, DNA, and protein, all to an equal degree (23) .
Streptonigrin was also reported to preferentially inhibit DNA synthesis in a number of strains of Salmonella typhimurium and Escherichia coli and to be an excellent inducer of phage production in inducible lysogenic bacteria (5) .
The chemistry of streptonigrin has recently been reviewed (14, 21) . Its empirical formula is C25H2208N4 and its structural formula (14) Although a microbiological assay employing Micrococcus pyogenes var. aureus was apparently used in the initial isolation of streptonigrin, no details of the procedure are available (15) .
MATERIALS AND METHODS Streptonigrin was tested against approximately 100 strains of microogranisms. Previously described methods were used to find an appropriate microorganism for the assay of streptonigrin (4, 12) . Bacillus subtilis ATCC 6633 was selected as the assay microorganism because of its unique sensitivity to streptonigrin. The culture is maintained on tryptic soy agar slants (Difco). For the assay, broth cultures of B.
subtilis were grown for 16 to 18 h at 37 C in tryptic soy broth. Cells from these cultures were collected and washed by centrifugation in saline (0.85% NaCl), resuspended in saline, and adjusted to 20% light transmittance (660 nm) in a Spectronic-20 colorimeter (Bausch & Lomb, Inc., Rochester, N.Y.). A 0.5-ml amount of this cell suspension was added to 1 liter of cooled (50 C) tryptic soy agar medium adjusted to pH 6.3, and a 6-ml amount of the inoculated agar was dispensed into assay plates (100 by 15 mm, Lab-Tex Products).
Stock solutions of streptonigrin prepared in sterile saline (0.85% NaCl), in freshly collected mouse blood and in serum, were diluted to yield appropriate concentrations when a 0.08-ml amount was pipetted onto filter paper disks (1.27 cm in diameter, no. 740-E, Schleicher & Schuell Co., Keene, N.H.). Concentrations obtained were: 0.01, 0.02, 0.04, 0.06, 0.08, 0.1, 0.2, 0.4, 0.6, 0.8, and 1.0 ug per disk of streptonigrin. The saturated filter paper disks were placed on the surface of each seeded agar plate and were pressed down securely with sterile forceps. All plates and drug concentrations per disk were prepared in triplicate. Each individual plate contained a maximum of three disks. Two disks contained, individually, either experimental samples (tissue homogenates or body fluids) or standard solutions of different concentrations. A third control disk, containing an empirically selected concentration (0.2 gig of streptonigrin per disk), was added to each plate, which allowed for the correction of plate-to-plate variation in zone sizes.All plates with disks were held for 24 h at 4 C prior to incubation at 30 C for 18 to 22 h. The resulting zones of inhibition on the plates were measured and corrected as previously reported (13) . The corrected mean diameters of the zones of inhibition surrounding the disks, which contained known concentrations of drug, were plotted on semilogarithmic graph paper, the zone sizes on the arithmetic scale, and drug concentrations per disk on the logarithmic scale. Standard curves were constructed through the points thus obtained by the method of least squares. Drug concentrations in the experimental samples were obtained by reading the drug concentrations on the ordinate of the blood standard curve, which corresponded to the size of the corrected zones of inhibition surrounding the disks impregnated with tissue preparations or body fluids.
BDF, mice (mixed sexes, 18 to 22 g) were used in all experiments. Blood samples were obtained by cardiac puncture of sacrificed mice. Urine samples were collected directly from the bladder of sacrificed mice. Care was taken to remove excess blood from the extracted tissues by blotting with absorbent tissue. All tissues and body fluids were frozen and stored overnight. The samples were then thawed and prepared for assaying by homogenizing weighed tissues in an Omni-Mixer (Ivan Sorvall, Inc., Norwalk, Conn.) containing 1 ml of saline. The individual tissues were pooled before assaying, with the exception of blood and urine, which were assayed individually.
RESULTS AND DISCUSSION
Representative standard assay curves of streptonigrin in mouse blood, saline, and in serum are graphically illustrated in Fig. 1 
